Sign In
News Digest /
Latest Stock Market News /
Earnings Alert: ASML and Abbott Lead a Packed Earnings Day on October 16, 2024
Earnings Alert: ASML and Abbott Lead a Packed Earnings Day on October 16, 2024
Samuel Brooks
05:02am, Wednesday, Oct 16, 2024
Photo: Envato.com
Today, several companies are set to release their earnings, including tech giant ASML and healthcare leader Abbott Laboratories:
Earnings Calendar for October 16, 2024
| Date | Day | Company | Ticker | When | Exchange | Market Cap (B) | Consensus EPS | Earnings Date | Ending Fiscal Quarter |
| Oct 16 | Wednesday | ASML Holding | ASML | BMO | NASDAQ | 343.17 | 5.24 | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Abbott Laboratories | ABT | BMO | NYSE | 204.003 | 1.2 | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PO | BMO | NYSE | 179.403 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PL | BMO | NYSE | 179.232 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PF | BMO | NYSE | 179.133 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PA | BMO | NYSE | 179.1 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PP | BMO | NYSE | 179.046 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PI | BMO | NYSE | 178.849 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PE | BMO | NYSE | 178.639 | N/A | 2024-10-16 | Sep, 2024 |
| Oct 16 | Wednesday | Morgan Stanley | MS-PK | BMO | NYSE | 178.221 | N/A | 2024-10-16 | Sep, 2024 |
Highlights and Expectations:
ASML Holding (NASDAQ:ASML): As one of the leaders in semiconductor manufacturing, ASML's earnings report is closely watched. With a consensus EPS of 5.24, investors will be keen to see how the company is managing supply chain challenges and demand fluctuations amidst the macroeconomic climate.
Abbott Laboratories (NYSE:ABT): Abbott is expected to report an EPS of 1.20. The healthcare giant will likely provide insights on its performance in diagnostic and medical device segments, particularly amidst ongoing health challenges globally.
About The Author
Samuel Brooks
Read Next in Latest Stock Market News
View All News
Trusted Broker
Start Your Journey With:
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs